Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

News

From: Regulatory

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

Races to become first-in-class

From: Sales

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Continues to bulk up its pipeline

From: Regulatory

AbbVie/Allergan's merger faces public opposition

Advocacy groups and unions in the US express concerns

From: Research

Celgene’s ‘oral Vidaza’ clears phase 3 leukaemia trial

Regulatory filings expected in first half of 2020

More news

Articles

The dawn of a new era in medical education

By Annlouise Pendse
How can we realise the benefits of patient engagement?

By Stephen O’Farrell and Nadine van Dongen
The power of high-value, highly relevant content to support clinical decisions

by Sandrine Veillet
Breaking free

Pharma’s ability to understand and modify customer behaviour is improving – but is it doing enough?
The evolution of real-world studies

How industry and regulators are using real-world data

Digital Edition

Pharmaceutical Market Europe - September 2019

Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but a foe.

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app